The diagnosis and treatment of breast cancer has a substantial impact on health, emotional well-being and quality of life. Adjuvant systemic therapy (the administration of chemotherapy, endocrine or biologic therapy) is a distinct phase of breast cancer treatment following primary treatment [1]. Adjuvant systemic therapy is currently recommended to most women with newly diagnosed breast cancer and is associated with declining mortality for women with breast cancer [2, 3]. Every year in the United States approximately 200,000 women are diagnosed with breast cancer [4].
展开▼
